Evelyne Lerut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Evelyne Lerut has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Steven Joniau
Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium
23 shared publications - Hendrik Van Poppel
Department of Urology, KU Leuven, Leuven, Belgium
22 shared publications - Burkhard Kneitz
Department of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany
21 shared publications - Charis Kalogirou
Würzburg, Germany
21 shared publications - Claus-Jürgen Scholz
Wisplinghoff Laboratories, Cologne, Germany
21 shared publications Hubertus Riedmiller
21 shared publications
Latest Publications
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 33K, Upregulation of miR-221 in pre miR-221 transfected cell lines.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 33K, Upregulation of miR-221 in pre miR-221 transfected cell lines.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 61K, Interferon signaling pathway and Enriched pathways based on lists of down-regulated or up-regulated genes.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 61K, Interferon signaling pathway and Enriched pathways based on lists of down-regulated or up-regulated genes.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 33K, Upregulation of miR-221 in pre miR-221 transfected cell lines.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 33K, Upregulation of miR-221 in pre miR-221 transfected cell lines.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 27K, Flow charts demonstrating the patient selection.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 27K, Flow charts demonstrating the patient selection.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 27K, Flow charts demonstrating the patient selection.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 27K, Flow charts demonstrating the patient selection.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
XLSX file - 90K, List of up and downregulated genes.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
XLSX file - 90K, List of up and downregulated genes.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 30K, Mir-221 expression decrease mRNA expression levels of SOCS3 or IRF2.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 30K, Mir-221 expression decrease mRNA expression levels of SOCS3 or IRF2.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 30K, Stable miR-221 expression in PC-3 clones mediates growth inhibition and activates genes involved in the interferon signaling pathway.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 30K, Stable miR-221 expression in PC-3 clones mediates growth inhibition and activates genes involved in the interferon signaling pathway.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 220K, MiR-221 down-regulation predicts clinical failure (CF) in high-risk prostate cancer.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
PDF file - 220K, MiR-221 down-regulation predicts clinical failure (CF) in high-risk prostate cancer.